Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 14Withdrawn 3Unknown 3Terminated 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1

Conditions

Vomiting 3Nausea 1Lymphoma, Non-Hodgkin 1Lymphoma 1Glioma 1

Interventions

Ondansetron 3Granisetron 3Aprepitant 2casopitant 1Vincristine 1Tropisetron 1Therapeutics 1Rituximab 1R-CHOP protocol 1Psychiatric Rehabilitation 1Prochlorperazine 1Prednisolone 1Palonosetron 1Metoclopramide 1Lorazepam 1Exercise 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Antiemetics 1Acupuncture Points 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Vomiting × Granisetron × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT01596413 2024-07-26

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

Kyowa Kirin Co., Ltd.

Phase 1 Withdrawn

Vomiting

NCT01596426 2024-07-26

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Kyowa Kirin Co., Ltd.

Phase 1 Withdrawn

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡